Delivery Order SPE2DB20D1050-SPE2DB25FH47A

Award Date 1/27/25
Potential Completion Date 2/18/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,740.00, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award, valued at $12,740.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of the drug BRUKINSA 80 MG CAPSULE 120S. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of February 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,480.00, is a delivery order for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has a period of performance through March 18, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a performance period running through March 4, 2025. This is a Firm Fixed Price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of medical products, including BRUKINSA 80 MG CAPSULE 120S. The award, with a ceiling value of $6,370.00, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is a Delivery Order for the supply of 4567720736 BRUKINSA 80 MG CAPSULE 120S. It is a Firm Fixed Price contract with an ultimate completion date of April 17, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,985,646 units of the medication BRUKINSA 80 MG CAPSULE 120S. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on May 12, 2025. This award is not associated with a set-aside program and is considered open competition. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB25FH47A
    Delivery Order

This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a completion date of February 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 4/28/25, 9:43 AM